bpc-157 human case report side effects This doesn't mean is side-effect-free. But it does add to the safety signal. Credit to @dr.kseniamiami for mentioning this study on our recent podcast recording last week which will be out What no one's telling you

Because oral and injectable delivery methods may differ significantly in absorption, equivalent dosing is not always a one-to-one conversion

Martin TG, Mateos MV, Nooka A, et al

Each unit now contains 0.05 mg (50 mcg)

Tesamorelins FDA approval is specifically for HIV-associated lipodystrophy, so off-label use for general visceral fat reduction is patient-pay

You can browse the full research peptides catalogue for related compounds

Read more: #FDA #CompoundingPharmacy #Pharma #HealthcareLaw #FrierLevitt To view or add a comment, sign in If you run a clinic that has been waiting for clarity on the peptide regulatory landscape, last week brought the clearest signal we have seen in a long time